fda 503a bulks list peptides bpc-157 just got voted in favor to be added to the Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank 3 FOR 3. An FDA

3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval Big week for peptides. On July 2324, the FDA's Pharmacy Compounding Advisory Committee will review seven peptide related groups for potential inclusion on the 503A Bulks List. The committee will hear evidence, discuss Big decisions could be coming for peptide compounding. Over the next few days, the FDA's Pharmacy Compounding Advisory Committee will discuss several peptides, including BPC 157, and whether they should be considered for FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline Industry Update: Interim 503A and 503B Bulks Lists New Revisions FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT

SKU: 79300729414 · From www.coppermineslodge.com